Author

Stephanie Amiridis

Observed name: S. Amiridis

Observed institutions: The Royal Melbourne Hospital, The University of Melbourne, NHS Grampian

OpenAlex ID: A5043423822

Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity

2017 · Daniel V. Brown, Gulay Filiz, et al. · PLoS ONE · 157

The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells

2015 · Jared Ching, Stephanie Amiridis, et al. · Oncotarget · 33

Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma

2019 · Rodney Luwor, Andrew P. Morokoff, et al. · Cancer Investigation · 23

A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: Increasing glutamate uptake with PPARγ agonists

2014 · Jared Ching, Stephanie Amiridis, et al. · Journal of Clinical Neuroscience · 12

Optimizing lipid-lowering therapy for acute coronary syndrome using a decision support system: insights from a cluster randomized trial

2025 · Christophe A T Stevens, Jessica Smith, et al. · European Heart Journal - Digital Health · 2

Op35 * the Ppar Agonist Pioglitazone Upregulates Eaat2 Expression in Human Glioblastoma Cells

2014 · J. Ching, S. Amiridis, et al. · Neuro-Oncology

THE PPAR gamma AGONIST PIOGLITAZONE UPREGULATES EAAT2 EXPRESSION IN HUMAN GLIOBLASTOMA CELLS

2014 · Jared Ching, Stephanie Amiridis, et al. · Neuro-Oncology

Works count: 7

Citation count: 227

H-index: 4

I10-index: 4